nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—HTR1A—Parkinson's disease	0.239	0.341	CbGaD
Trifluoperazine—DRD2—Parkinson's disease	0.203	0.289	CbGaD
Trifluoperazine—HTR2A—Parkinson's disease	0.157	0.224	CbGaD
Trifluoperazine—ABCB1—Parkinson's disease	0.102	0.146	CbGaD
Trifluoperazine—CALM1—superior cervical ganglion—Parkinson's disease	0.00573	0.0477	CbGeAlD
Trifluoperazine—CALM2—adrenal medulla—Parkinson's disease	0.00472	0.0393	CbGeAlD
Trifluoperazine—CALM1—adrenal medulla—Parkinson's disease	0.0047	0.0391	CbGeAlD
Trifluoperazine—HTR2A—enteric nervous system—Parkinson's disease	0.00365	0.0303	CbGeAlD
Trifluoperazine—CALM1—sympathetic nervous system—Parkinson's disease	0.00312	0.026	CbGeAlD
Trifluoperazine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00276	0.023	CbGeAlD
Trifluoperazine—HTR2A—locus ceruleus—Parkinson's disease	0.00241	0.02	CbGeAlD
Trifluoperazine—CALM2—pons—Parkinson's disease	0.00229	0.019	CbGeAlD
Trifluoperazine—CALM1—pons—Parkinson's disease	0.00228	0.019	CbGeAlD
Trifluoperazine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00228	0.0189	CbGeAlD
Trifluoperazine—CALM1—autonomic nervous system—Parkinson's disease	0.0021	0.0175	CbGeAlD
Trifluoperazine—HTR2A—cerebellar cortex—Parkinson's disease	0.00196	0.0163	CbGeAlD
Trifluoperazine—S100A4—embryo—Parkinson's disease	0.00193	0.0161	CbGeAlD
Trifluoperazine—HTR1A—telencephalic ventricle—Parkinson's disease	0.00192	0.0159	CbGeAlD
Trifluoperazine—HTR2A—sympathetic nervous system—Parkinson's disease	0.0019	0.0158	CbGeAlD
Trifluoperazine—DRD2—telencephalic ventricle—Parkinson's disease	0.00173	0.0144	CbGeAlD
Trifluoperazine—CALM2—peripheral nervous system—Parkinson's disease	0.00152	0.0127	CbGeAlD
Trifluoperazine—CALM1—peripheral nervous system—Parkinson's disease	0.00152	0.0126	CbGeAlD
Trifluoperazine—S100A4—cardiovascular system—Parkinson's disease	0.00144	0.012	CbGeAlD
Trifluoperazine—CALY—medulla oblongata—Parkinson's disease	0.00143	0.0119	CbGeAlD
Trifluoperazine—HTR2A—pons—Parkinson's disease	0.00139	0.0115	CbGeAlD
Trifluoperazine—CALY—midbrain—Parkinson's disease	0.00131	0.0109	CbGeAlD
Trifluoperazine—HTR2A—autonomic nervous system—Parkinson's disease	0.00128	0.0106	CbGeAlD
Trifluoperazine—CALY—spinal cord—Parkinson's disease	0.00127	0.0106	CbGeAlD
Trifluoperazine—EBPL—head—Parkinson's disease	0.00124	0.0103	CbGeAlD
Trifluoperazine—S100A4—medulla oblongata—Parkinson's disease	0.00123	0.0103	CbGeAlD
Trifluoperazine—TNNC1—cardiovascular system—Parkinson's disease	0.00122	0.0101	CbGeAlD
Trifluoperazine—CALM2—nerve—Parkinson's disease	0.00119	0.00988	CbGeAlD
Trifluoperazine—CALM1—nerve—Parkinson's disease	0.00118	0.00983	CbGeAlD
Trifluoperazine—EBPL—nervous system—Parkinson's disease	0.00117	0.00977	CbGeAlD
Trifluoperazine—HTR2A—telencephalic ventricle—Parkinson's disease	0.00114	0.0095	CbGeAlD
Trifluoperazine—CALY—head—Parkinson's disease	0.00113	0.00943	CbGeAlD
Trifluoperazine—EBPL—central nervous system—Parkinson's disease	0.00113	0.00941	CbGeAlD
Trifluoperazine—S100A4—midbrain—Parkinson's disease	0.00113	0.00939	CbGeAlD
Trifluoperazine—EBPL—cerebellum—Parkinson's disease	0.00111	0.0092	CbGeAlD
Trifluoperazine—S100A4—spinal cord—Parkinson's disease	0.0011	0.00916	CbGeAlD
Trifluoperazine—DRD2—nerve—Parkinson's disease	0.00109	0.00908	CbGeAlD
Trifluoperazine—CALY—nervous system—Parkinson's disease	0.00107	0.00894	CbGeAlD
Trifluoperazine—CALY—central nervous system—Parkinson's disease	0.00103	0.00861	CbGeAlD
Trifluoperazine—HTR6—forebrain—Parkinson's disease	0.00103	0.00856	CbGeAlD
Trifluoperazine—CALY—cerebellum—Parkinson's disease	0.00101	0.00841	CbGeAlD
Trifluoperazine—S100A4—head—Parkinson's disease	0.000978	0.00814	CbGeAlD
Trifluoperazine—HTR2A—peripheral nervous system—Parkinson's disease	0.000923	0.00768	CbGeAlD
Trifluoperazine—HTR1A—hindbrain—Parkinson's disease	0.000904	0.00753	CbGeAlD
Trifluoperazine—EBPL—brain—Parkinson's disease	0.000898	0.00747	CbGeAlD
Trifluoperazine—CALM2—hindbrain—Parkinson's disease	0.000889	0.0074	CbGeAlD
Trifluoperazine—CALM1—hindbrain—Parkinson's disease	0.000885	0.00736	CbGeAlD
Trifluoperazine—S100A4—cerebellum—Parkinson's disease	0.000873	0.00726	CbGeAlD
Trifluoperazine—ADRA1A—hindbrain—Parkinson's disease	0.000834	0.00694	CbGeAlD
Trifluoperazine—CALY—brain—Parkinson's disease	0.000821	0.00683	CbGeAlD
Trifluoperazine—DRD2—hindbrain—Parkinson's disease	0.000817	0.0068	CbGeAlD
Trifluoperazine—Flupentixol—DDC—Parkinson's disease	0.000745	0.0775	CrCbGaD
Trifluoperazine—HTR2A—nerve—Parkinson's disease	0.00072	0.00599	CbGeAlD
Trifluoperazine—S100A4—brain—Parkinson's disease	0.000709	0.0059	CbGeAlD
Trifluoperazine—CHRM2—forebrain—Parkinson's disease	0.000617	0.00513	CbGeAlD
Trifluoperazine—HTR2C—brainstem—Parkinson's disease	0.000616	0.00512	CbGeAlD
Trifluoperazine—HTR2C—forebrain—Parkinson's disease	0.000594	0.00495	CbGeAlD
Trifluoperazine—HTR6—head—Parkinson's disease	0.000589	0.0049	CbGeAlD
Trifluoperazine—HTR6—nervous system—Parkinson's disease	0.000558	0.00465	CbGeAlD
Trifluoperazine—CALM2—embryo—Parkinson's disease	0.000556	0.00463	CbGeAlD
Trifluoperazine—CALM1—embryo—Parkinson's disease	0.000553	0.00461	CbGeAlD
Trifluoperazine—HTR2A—hindbrain—Parkinson's disease	0.000539	0.00449	CbGeAlD
Trifluoperazine—HTR6—central nervous system—Parkinson's disease	0.000538	0.00447	CbGeAlD
Trifluoperazine—CHRM2—cardiovascular system—Parkinson's disease	0.000521	0.00434	CbGeAlD
Trifluoperazine—HTR1A—brainstem—Parkinson's disease	0.000518	0.00431	CbGeAlD
Trifluoperazine—CALM2—brainstem—Parkinson's disease	0.000509	0.00424	CbGeAlD
Trifluoperazine—CALM1—brainstem—Parkinson's disease	0.000507	0.00422	CbGeAlD
Trifluoperazine—HTR1A—forebrain—Parkinson's disease	0.0005	0.00416	CbGeAlD
Trifluoperazine—CALM2—forebrain—Parkinson's disease	0.000492	0.00409	CbGeAlD
Trifluoperazine—CALM1—forebrain—Parkinson's disease	0.000489	0.00407	CbGeAlD
Trifluoperazine—ADRA1A—brainstem—Parkinson's disease	0.000478	0.00398	CbGeAlD
Trifluoperazine—DRD2—brainstem—Parkinson's disease	0.000468	0.0039	CbGeAlD
Trifluoperazine—ADRA1A—forebrain—Parkinson's disease	0.000461	0.00384	CbGeAlD
Trifluoperazine—CALM3—medulla oblongata—Parkinson's disease	0.000452	0.00376	CbGeAlD
Trifluoperazine—DRD2—forebrain—Parkinson's disease	0.000452	0.00376	CbGeAlD
Trifluoperazine—HTR2C—medulla oblongata—Parkinson's disease	0.000429	0.00357	CbGeAlD
Trifluoperazine—HTR6—brain—Parkinson's disease	0.000427	0.00355	CbGeAlD
Trifluoperazine—HTR1A—cardiovascular system—Parkinson's disease	0.000423	0.00352	CbGeAlD
Trifluoperazine—CALM2—cardiovascular system—Parkinson's disease	0.000416	0.00346	CbGeAlD
Trifluoperazine—CALM1—cardiovascular system—Parkinson's disease	0.000414	0.00344	CbGeAlD
Trifluoperazine—CALM3—midbrain—Parkinson's disease	0.000413	0.00344	CbGeAlD
Trifluoperazine—SIGMAR1—medulla oblongata—Parkinson's disease	0.000404	0.00336	CbGeAlD
Trifluoperazine—CALM3—spinal cord—Parkinson's disease	0.000403	0.00336	CbGeAlD
Trifluoperazine—HTR2C—midbrain—Parkinson's disease	0.000392	0.00327	CbGeAlD
Trifluoperazine—ADRA1A—cardiovascular system—Parkinson's disease	0.00039	0.00325	CbGeAlD
Trifluoperazine—HTR2C—spinal cord—Parkinson's disease	0.000383	0.00319	CbGeAlD
Trifluoperazine—SIGMAR1—midbrain—Parkinson's disease	0.00037	0.00308	CbGeAlD
Trifluoperazine—SIGMAR1—spinal cord—Parkinson's disease	0.000361	0.003	CbGeAlD
Trifluoperazine—HRH1—forebrain—Parkinson's disease	0.000357	0.00297	CbGeAlD
Trifluoperazine—CALM2—medulla oblongata—Parkinson's disease	0.000355	0.00296	CbGeAlD
Trifluoperazine—CALM1—medulla oblongata—Parkinson's disease	0.000354	0.00294	CbGeAlD
Trifluoperazine—CHRM2—head—Parkinson's disease	0.000353	0.00294	CbGeAlD
Trifluoperazine—HTR2C—head—Parkinson's disease	0.00034	0.00283	CbGeAlD
Trifluoperazine—HTR2A—embryo—Parkinson's disease	0.000337	0.00281	CbGeAlD
Trifluoperazine—CHRM2—nervous system—Parkinson's disease	0.000335	0.00279	CbGeAlD
Trifluoperazine—HTR1A—midbrain—Parkinson's disease	0.00033	0.00275	CbGeAlD
Trifluoperazine—CALM2—midbrain—Parkinson's disease	0.000325	0.0027	CbGeAlD
Trifluoperazine—CALM1—midbrain—Parkinson's disease	0.000323	0.00269	CbGeAlD
Trifluoperazine—HTR2C—nervous system—Parkinson's disease	0.000323	0.00269	CbGeAlD
Trifluoperazine—HTR1A—spinal cord—Parkinson's disease	0.000322	0.00268	CbGeAlD
Trifluoperazine—CHRM2—central nervous system—Parkinson's disease	0.000322	0.00268	CbGeAlD
Trifluoperazine—CALM3—cerebellum—Parkinson's disease	0.00032	0.00266	CbGeAlD
Trifluoperazine—CALM2—spinal cord—Parkinson's disease	0.000317	0.00264	CbGeAlD
Trifluoperazine—CALM1—spinal cord—Parkinson's disease	0.000315	0.00262	CbGeAlD
Trifluoperazine—HTR2C—central nervous system—Parkinson's disease	0.000311	0.00259	CbGeAlD
Trifluoperazine—HTR2A—brainstem—Parkinson's disease	0.000309	0.00257	CbGeAlD
Trifluoperazine—DRD2—midbrain—Parkinson's disease	0.000298	0.00248	CbGeAlD
Trifluoperazine—HTR2A—forebrain—Parkinson's disease	0.000298	0.00248	CbGeAlD
Trifluoperazine—HTR1A—head—Parkinson's disease	0.000286	0.00238	CbGeAlD
Trifluoperazine—SIGMAR1—cerebellum—Parkinson's disease	0.000286	0.00238	CbGeAlD
Trifluoperazine—CALM2—head—Parkinson's disease	0.000282	0.00234	CbGeAlD
Trifluoperazine—CALM1—head—Parkinson's disease	0.00028	0.00233	CbGeAlD
Trifluoperazine—HTR1A—nervous system—Parkinson's disease	0.000272	0.00226	CbGeAlD
Trifluoperazine—CALM2—nervous system—Parkinson's disease	0.000267	0.00222	CbGeAlD
Trifluoperazine—CALM1—nervous system—Parkinson's disease	0.000266	0.00221	CbGeAlD
Trifluoperazine—ADRA1A—head—Parkinson's disease	0.000264	0.0022	CbGeAlD
Trifluoperazine—HTR1A—central nervous system—Parkinson's disease	0.000261	0.00218	CbGeAlD
Trifluoperazine—CALM3—brain—Parkinson's disease	0.00026	0.00216	CbGeAlD
Trifluoperazine—DRD2—head—Parkinson's disease	0.000259	0.00215	CbGeAlD
Trifluoperazine—CALM2—central nervous system—Parkinson's disease	0.000257	0.00214	CbGeAlD
Trifluoperazine—CHRM2—brain—Parkinson's disease	0.000256	0.00213	CbGeAlD
Trifluoperazine—CALM1—central nervous system—Parkinson's disease	0.000256	0.00213	CbGeAlD
Trifluoperazine—HTR1A—cerebellum—Parkinson's disease	0.000256	0.00213	CbGeAlD
Trifluoperazine—HTR2A—cardiovascular system—Parkinson's disease	0.000252	0.0021	CbGeAlD
Trifluoperazine—CALM2—cerebellum—Parkinson's disease	0.000251	0.00209	CbGeAlD
Trifluoperazine—ADRA1A—nervous system—Parkinson's disease	0.00025	0.00208	CbGeAlD
Trifluoperazine—CALM1—cerebellum—Parkinson's disease	0.00025	0.00208	CbGeAlD
Trifluoperazine—HTR2C—brain—Parkinson's disease	0.000247	0.00205	CbGeAlD
Trifluoperazine—DRD2—nervous system—Parkinson's disease	0.000245	0.00204	CbGeAlD
Trifluoperazine—ADRA1A—central nervous system—Parkinson's disease	0.000241	0.00201	CbGeAlD
Trifluoperazine—DRD2—central nervous system—Parkinson's disease	0.000236	0.00197	CbGeAlD
Trifluoperazine—ADRA1A—cerebellum—Parkinson's disease	0.000236	0.00196	CbGeAlD
Trifluoperazine—SIGMAR1—brain—Parkinson's disease	0.000232	0.00193	CbGeAlD
Trifluoperazine—DRD2—cerebellum—Parkinson's disease	0.000231	0.00192	CbGeAlD
Trifluoperazine—Flupentixol—DRD1—Parkinson's disease	0.000228	0.0237	CrCbGaD
Trifluoperazine—ABCB1—embryo—Parkinson's disease	0.000221	0.00184	CbGeAlD
Trifluoperazine—HTR2A—medulla oblongata—Parkinson's disease	0.000215	0.00179	CbGeAlD
Trifluoperazine—HTR1A—brain—Parkinson's disease	0.000208	0.00173	CbGeAlD
Trifluoperazine—HRH1—head—Parkinson's disease	0.000204	0.0017	CbGeAlD
Trifluoperazine—CALM2—brain—Parkinson's disease	0.000204	0.0017	CbGeAlD
Trifluoperazine—CALM1—brain—Parkinson's disease	0.000203	0.00169	CbGeAlD
Trifluoperazine—Acetophenazine—DRD1—Parkinson's disease	0.000203	0.0211	CrCbGaD
Trifluoperazine—HTR2A—midbrain—Parkinson's disease	0.000197	0.00164	CbGeAlD
Trifluoperazine—ABCB1—forebrain—Parkinson's disease	0.000195	0.00163	CbGeAlD
Trifluoperazine—HRH1—nervous system—Parkinson's disease	0.000194	0.00161	CbGeAlD
Trifluoperazine—HTR2A—spinal cord—Parkinson's disease	0.000192	0.0016	CbGeAlD
Trifluoperazine—ADRA1A—brain—Parkinson's disease	0.000191	0.00159	CbGeAlD
Trifluoperazine—DRD2—brain—Parkinson's disease	0.000188	0.00156	CbGeAlD
Trifluoperazine—HRH1—central nervous system—Parkinson's disease	0.000187	0.00155	CbGeAlD
Trifluoperazine—Propericiazine—DRD1—Parkinson's disease	0.000179	0.0186	CrCbGaD
Trifluoperazine—HTR2A—head—Parkinson's disease	0.000171	0.00142	CbGeAlD
Trifluoperazine—ABCB1—cardiovascular system—Parkinson's disease	0.000165	0.00137	CbGeAlD
Trifluoperazine—HTR2A—nervous system—Parkinson's disease	0.000162	0.00135	CbGeAlD
Trifluoperazine—Flupentixol—DRD2—Parkinson's disease	0.000161	0.0167	CrCbGaD
Trifluoperazine—HTR2A—central nervous system—Parkinson's disease	0.000156	0.0013	CbGeAlD
Trifluoperazine—HTR2A—cerebellum—Parkinson's disease	0.000152	0.00127	CbGeAlD
Trifluoperazine—HRH1—brain—Parkinson's disease	0.000148	0.00123	CbGeAlD
Trifluoperazine—Acetophenazine—DRD2—Parkinson's disease	0.000143	0.0149	CrCbGaD
Trifluoperazine—ABCB1—medulla oblongata—Parkinson's disease	0.000141	0.00117	CbGeAlD
Trifluoperazine—ABCB1—midbrain—Parkinson's disease	0.000129	0.00107	CbGeAlD
Trifluoperazine—Zuclopenthixol—DRD1—Parkinson's disease	0.000128	0.0133	CrCbGaD
Trifluoperazine—ABCB1—spinal cord—Parkinson's disease	0.000126	0.00105	CbGeAlD
Trifluoperazine—Flupentixol—HTR2A—Parkinson's disease	0.000124	0.0129	CrCbGaD
Trifluoperazine—Triflupromazine—DRD1—Parkinson's disease	0.000124	0.0129	CrCbGaD
Trifluoperazine—HTR2A—brain—Parkinson's disease	0.000124	0.00103	CbGeAlD
Trifluoperazine—Nefazodone—SLC6A3—Parkinson's disease	0.000121	0.0126	CrCbGaD
Trifluoperazine—Clomipramine—GSTP1—Parkinson's disease	0.000116	0.012	CrCbGaD
Trifluoperazine—Acepromazine—DRD1—Parkinson's disease	0.000115	0.012	CrCbGaD
Trifluoperazine—Thioproperazine—DRD1—Parkinson's disease	0.000112	0.0117	CrCbGaD
Trifluoperazine—ABCB1—head—Parkinson's disease	0.000112	0.000931	CbGeAlD
Trifluoperazine—Mesoridazine—DRD3—Parkinson's disease	0.000111	0.0116	CrCbGaD
Trifluoperazine—Thiothixene—DRD1—Parkinson's disease	0.000111	0.0115	CrCbGaD
Trifluoperazine—Pipotiazine—DRD1—Parkinson's disease	0.000111	0.0115	CrCbGaD
Trifluoperazine—Prochlorperazine—DRD3—Parkinson's disease	0.000108	0.0112	CrCbGaD
Trifluoperazine—ABCB1—nervous system—Parkinson's disease	0.000106	0.000883	CbGeAlD
Trifluoperazine—Nefazodone—HTR1A—Parkinson's disease	0.000106	0.011	CrCbGaD
Trifluoperazine—ABCB1—central nervous system—Parkinson's disease	0.000102	0.00085	CbGeAlD
Trifluoperazine—ABCB1—cerebellum—Parkinson's disease	9.98e-05	0.000831	CbGeAlD
Trifluoperazine—Trazodone—HTR1A—Parkinson's disease	9.8e-05	0.0102	CrCbGaD
Trifluoperazine—Cyamemazine—HTR2A—Parkinson's disease	9.75e-05	0.0101	CrCbGaD
Trifluoperazine—Fluphenazine—DRD3—Parkinson's disease	9.74e-05	0.0101	CrCbGaD
Trifluoperazine—Fluphenazine—DRD1—Parkinson's disease	9.56e-05	0.00994	CrCbGaD
Trifluoperazine—Acepromazine—HTR1A—Parkinson's disease	9.55e-05	0.00993	CrCbGaD
Trifluoperazine—Thioproperazine—HTR1A—Parkinson's disease	9.34e-05	0.00971	CrCbGaD
Trifluoperazine—Propiomazine—DRD1—Parkinson's disease	9.2e-05	0.00956	CrCbGaD
Trifluoperazine—Pipotiazine—HTR1A—Parkinson's disease	9.19e-05	0.00955	CrCbGaD
Trifluoperazine—Thiothixene—HTR1A—Parkinson's disease	9.19e-05	0.00955	CrCbGaD
Trifluoperazine—Mesoridazine—HTR1A—Parkinson's disease	9.07e-05	0.00942	CrCbGaD
Trifluoperazine—Zuclopenthixol—DRD2—Parkinson's disease	9.04e-05	0.0094	CrCbGaD
Trifluoperazine—Thioridazine—HTR7—Parkinson's disease	8.92e-05	0.00928	CrCbGaD
Trifluoperazine—Triflupromazine—DRD2—Parkinson's disease	8.76e-05	0.00911	CrCbGaD
Trifluoperazine—Thioridazine—DRD1—Parkinson's disease	8.24e-05	0.00856	CrCbGaD
Trifluoperazine—Loxapine—HTR7—Parkinson's disease	8.23e-05	0.00855	CrCbGaD
Trifluoperazine—Perphenazine—HTR7—Parkinson's disease	8.19e-05	0.00851	CrCbGaD
Trifluoperazine—Flupentixol—ABCB1—Parkinson's disease	8.12e-05	0.00844	CrCbGaD
Trifluoperazine—Acepromazine—DRD2—Parkinson's disease	8.11e-05	0.00843	CrCbGaD
Trifluoperazine—ABCB1—brain—Parkinson's disease	8.11e-05	0.000675	CbGeAlD
Trifluoperazine—Quetiapine—HTR7—Parkinson's disease	8.03e-05	0.00835	CrCbGaD
Trifluoperazine—Methotrimeprazine—DRD3—Parkinson's disease	8.01e-05	0.00833	CrCbGaD
Trifluoperazine—Fluphenazine—HTR1A—Parkinson's disease	7.94e-05	0.00825	CrCbGaD
Trifluoperazine—Thioproperazine—DRD2—Parkinson's disease	7.93e-05	0.00824	CrCbGaD
Trifluoperazine—Methotrimeprazine—DRD1—Parkinson's disease	7.86e-05	0.00817	CrCbGaD
Trifluoperazine—Thiothixene—DRD2—Parkinson's disease	7.8e-05	0.00811	CrCbGaD
Trifluoperazine—Pipotiazine—DRD2—Parkinson's disease	7.8e-05	0.00811	CrCbGaD
Trifluoperazine—Mequitazine—CYP2D6—Parkinson's disease	7.75e-05	0.00805	CrCbGaD
Trifluoperazine—Loxapine—DRD3—Parkinson's disease	7.74e-05	0.00804	CrCbGaD
Trifluoperazine—Mesoridazine—DRD2—Parkinson's disease	7.7e-05	0.008	CrCbGaD
Trifluoperazine—Loxapine—DRD1—Parkinson's disease	7.59e-05	0.00789	CrCbGaD
Trifluoperazine—Perphenazine—DRD1—Parkinson's disease	7.56e-05	0.00786	CrCbGaD
Trifluoperazine—Quetiapine—DRD3—Parkinson's disease	7.55e-05	0.00785	CrCbGaD
Trifluoperazine—Prochlorperazine—DRD2—Parkinson's disease	7.45e-05	0.00775	CrCbGaD
Trifluoperazine—Quetiapine—DRD1—Parkinson's disease	7.41e-05	0.0077	CrCbGaD
Trifluoperazine—Loxapine—SLC6A3—Parkinson's disease	7.2e-05	0.00748	CrCbGaD
Trifluoperazine—Zuclopenthixol—HTR2A—Parkinson's disease	6.99e-05	0.00727	CrCbGaD
Trifluoperazine—Nefazodone—HTR2A—Parkinson's disease	6.95e-05	0.00722	CrCbGaD
Trifluoperazine—Clozapine—HTR7—Parkinson's disease	6.91e-05	0.00718	CrCbGaD
Trifluoperazine—Thioridazine—HTR1A—Parkinson's disease	6.84e-05	0.00711	CrCbGaD
Trifluoperazine—Promazine—DRD1—Parkinson's disease	6.81e-05	0.00708	CrCbGaD
Trifluoperazine—Fluphenazine—DRD2—Parkinson's disease	6.74e-05	0.00701	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR7—Parkinson's disease	6.5e-05	0.00675	CrCbGaD
Trifluoperazine—Clozapine—DRD3—Parkinson's disease	6.5e-05	0.00675	CrCbGaD
Trifluoperazine—Fluphenazine—CYP2E1—Parkinson's disease	6.49e-05	0.00674	CrCbGaD
Trifluoperazine—Propiomazine—DRD2—Parkinson's disease	6.48e-05	0.00674	CrCbGaD
Trifluoperazine—Trazodone—HTR2A—Parkinson's disease	6.43e-05	0.00668	CrCbGaD
Trifluoperazine—Zuclopenthixol—CYP2D6—Parkinson's disease	6.39e-05	0.00664	CrCbGaD
Trifluoperazine—Clozapine—DRD1—Parkinson's disease	6.38e-05	0.00663	CrCbGaD
Trifluoperazine—Nefazodone—CYP2D6—Parkinson's disease	6.36e-05	0.00661	CrCbGaD
Trifluoperazine—Loxapine—HTR1A—Parkinson's disease	6.31e-05	0.00656	CrCbGaD
Trifluoperazine—Perphenazine—HTR1A—Parkinson's disease	6.28e-05	0.00653	CrCbGaD
Trifluoperazine—Acepromazine—HTR2A—Parkinson's disease	6.27e-05	0.00651	CrCbGaD
Trifluoperazine—Quetiapine—HTR1A—Parkinson's disease	6.16e-05	0.0064	CrCbGaD
Trifluoperazine—Thioproperazine—HTR2A—Parkinson's disease	6.12e-05	0.00637	CrCbGaD
Trifluoperazine—Chlorpromazine—DRD3—Parkinson's disease	6.11e-05	0.00635	CrCbGaD
Trifluoperazine—Thiothixene—HTR2A—Parkinson's disease	6.03e-05	0.00626	CrCbGaD
Trifluoperazine—Pipotiazine—HTR2A—Parkinson's disease	6.03e-05	0.00626	CrCbGaD
Trifluoperazine—Chlorpromazine—DRD1—Parkinson's disease	6e-05	0.00623	CrCbGaD
Trifluoperazine—Mesoridazine—HTR2A—Parkinson's disease	5.95e-05	0.00618	CrCbGaD
Trifluoperazine—Trazodone—CYP2D6—Parkinson's disease	5.88e-05	0.00611	CrCbGaD
Trifluoperazine—Thioridazine—DRD2—Parkinson's disease	5.81e-05	0.00604	CrCbGaD
Trifluoperazine—Thioridazine—CYP2E1—Parkinson's disease	5.59e-05	0.00581	CrCbGaD
Trifluoperazine—Methotrimeprazine—DRD2—Parkinson's disease	5.54e-05	0.00576	CrCbGaD
Trifluoperazine—Pipotiazine—CYP2D6—Parkinson's disease	5.51e-05	0.00573	CrCbGaD
Trifluoperazine—Thiothixene—CYP2D6—Parkinson's disease	5.51e-05	0.00573	CrCbGaD
Trifluoperazine—Promethazine—DRD2—Parkinson's disease	5.46e-05	0.00568	CrCbGaD
Trifluoperazine—Mesoridazine—CYP2D6—Parkinson's disease	5.44e-05	0.00565	CrCbGaD
Trifluoperazine—Loxapine—DRD2—Parkinson's disease	5.35e-05	0.00557	CrCbGaD
Trifluoperazine—Methotrimeprazine—CYP2E1—Parkinson's disease	5.34e-05	0.00555	CrCbGaD
Trifluoperazine—Perphenazine—DRD2—Parkinson's disease	5.33e-05	0.00554	CrCbGaD
Trifluoperazine—Clozapine—HTR1A—Parkinson's disease	5.3e-05	0.0055	CrCbGaD
Trifluoperazine—Prochlorperazine—CYP2D6—Parkinson's disease	5.27e-05	0.00547	CrCbGaD
Trifluoperazine—Quetiapine—DRD2—Parkinson's disease	5.23e-05	0.00543	CrCbGaD
Trifluoperazine—Fluphenazine—HTR2A—Parkinson's disease	5.21e-05	0.00541	CrCbGaD
Trifluoperazine—Propiomazine—HTR2A—Parkinson's disease	5.01e-05	0.00521	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR1A—Parkinson's disease	4.98e-05	0.00518	CrCbGaD
Trifluoperazine—Promazine—DRD2—Parkinson's disease	4.8e-05	0.00499	CrCbGaD
Trifluoperazine—Clomipramine—HTR2A—Parkinson's disease	4.76e-05	0.00495	CrCbGaD
Trifluoperazine—Fluphenazine—CYP2D6—Parkinson's disease	4.76e-05	0.00495	CrCbGaD
Trifluoperazine—Nefazodone—ABCB1—Parkinson's disease	4.54e-05	0.00472	CrCbGaD
Trifluoperazine—Clozapine—DRD2—Parkinson's disease	4.49e-05	0.00467	CrCbGaD
Trifluoperazine—Thioridazine—HTR2A—Parkinson's disease	4.49e-05	0.00466	CrCbGaD
Trifluoperazine—Triflupromazine—ABCB1—Parkinson's disease	4.42e-05	0.0046	CrCbGaD
Trifluoperazine—Clomipramine—CYP2D6—Parkinson's disease	4.36e-05	0.00453	CrCbGaD
Trifluoperazine—Clozapine—CYP2E1—Parkinson's disease	4.33e-05	0.0045	CrCbGaD
Trifluoperazine—Methotrimeprazine—HTR2A—Parkinson's disease	4.28e-05	0.00445	CrCbGaD
Trifluoperazine—Chlorpromazine—DRD2—Parkinson's disease	4.23e-05	0.00439	CrCbGaD
Trifluoperazine—Promethazine—HTR2A—Parkinson's disease	4.22e-05	0.00439	CrCbGaD
Trifluoperazine—Trazodone—ABCB1—Parkinson's disease	4.2e-05	0.00436	CrCbGaD
Trifluoperazine—Loxapine—HTR2A—Parkinson's disease	4.14e-05	0.0043	CrCbGaD
Trifluoperazine—Perphenazine—HTR2A—Parkinson's disease	4.12e-05	0.00428	CrCbGaD
Trifluoperazine—Thioridazine—CYP2D6—Parkinson's disease	4.1e-05	0.00427	CrCbGaD
Trifluoperazine—Chlorpromazine—CYP2E1—Parkinson's disease	4.07e-05	0.00423	CrCbGaD
Trifluoperazine—Quetiapine—HTR2A—Parkinson's disease	4.04e-05	0.0042	CrCbGaD
Trifluoperazine—Methotrimeprazine—CYP2D6—Parkinson's disease	3.92e-05	0.00407	CrCbGaD
Trifluoperazine—Promethazine—CYP2D6—Parkinson's disease	3.86e-05	0.00401	CrCbGaD
Trifluoperazine—Perphenazine—CYP2D6—Parkinson's disease	3.77e-05	0.00391	CrCbGaD
Trifluoperazine—Promazine—HTR2A—Parkinson's disease	3.71e-05	0.00386	CrCbGaD
Trifluoperazine—Quetiapine—CYP2D6—Parkinson's disease	3.69e-05	0.00384	CrCbGaD
Trifluoperazine—Clozapine—HTR2A—Parkinson's disease	3.47e-05	0.00361	CrCbGaD
Trifluoperazine—Fluphenazine—ABCB1—Parkinson's disease	3.4e-05	0.00354	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR2A—Parkinson's disease	3.27e-05	0.0034	CrCbGaD
Trifluoperazine—Clozapine—CYP2D6—Parkinson's disease	3.18e-05	0.0033	CrCbGaD
Trifluoperazine—Clomipramine—ABCB1—Parkinson's disease	3.11e-05	0.00323	CrCbGaD
Trifluoperazine—Chlorpromazine—CYP2D6—Parkinson's disease	2.99e-05	0.00311	CrCbGaD
Trifluoperazine—Promethazine—ABCB1—Parkinson's disease	2.76e-05	0.00286	CrCbGaD
Trifluoperazine—Quetiapine—ABCB1—Parkinson's disease	2.64e-05	0.00274	CrCbGaD
Trifluoperazine—Clozapine—ABCB1—Parkinson's disease	2.27e-05	0.00236	CrCbGaD
Trifluoperazine—Chlorpromazine—ABCB1—Parkinson's disease	2.13e-05	0.00222	CrCbGaD
Trifluoperazine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	8.04e-06	4.78e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	8.04e-06	4.78e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—NQO1—Parkinson's disease	7.99e-06	4.75e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—NQO1—Parkinson's disease	7.99e-06	4.75e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—FGB—Parkinson's disease	7.95e-06	4.72e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—HTR2A—Parkinson's disease	7.93e-06	4.71e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HGF—Parkinson's disease	7.92e-06	4.71e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HGF—Parkinson's disease	7.92e-06	4.71e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	7.91e-06	4.7e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	7.91e-06	4.7e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HTR1A—Parkinson's disease	7.91e-06	4.7e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	7.89e-06	4.69e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	7.89e-06	4.69e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—TH—Parkinson's disease	7.87e-06	4.68e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—TH—Parkinson's disease	7.87e-06	4.68e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	7.82e-06	4.65e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—CYCS—Parkinson's disease	7.81e-06	4.65e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TAC1—Parkinson's disease	7.79e-06	4.63e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	7.77e-06	4.62e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—FGB—Parkinson's disease	7.69e-06	4.57e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—FGB—Parkinson's disease	7.69e-06	4.57e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—HTR2A—Parkinson's disease	7.67e-06	4.56e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—HTR2A—Parkinson's disease	7.67e-06	4.56e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HTR1A—Parkinson's disease	7.65e-06	4.55e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HTR1A—Parkinson's disease	7.65e-06	4.55e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—DRD1—Parkinson's disease	7.64e-06	4.54e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by NGF—IL6—Parkinson's disease	7.57e-06	4.5e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—CYCS—Parkinson's disease	7.56e-06	4.49e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—CYCS—Parkinson's disease	7.56e-06	4.49e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	7.56e-06	4.49e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TAC1—Parkinson's disease	7.53e-06	4.48e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TAC1—Parkinson's disease	7.53e-06	4.48e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	7.52e-06	4.47e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	7.51e-06	4.46e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	7.47e-06	4.44e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—MAOB—Parkinson's disease	7.43e-06	4.42e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	7.43e-06	4.42e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—DRD3—Parkinson's disease	7.4e-06	4.4e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—DRD1—Parkinson's disease	7.39e-06	4.39e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—DRD1—Parkinson's disease	7.39e-06	4.39e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by NGF—IL6—Parkinson's disease	7.32e-06	4.35e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by NGF—IL6—Parkinson's disease	7.32e-06	4.35e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—DRD3—Parkinson's disease	7.15e-06	4.25e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—DRD3—Parkinson's disease	7.15e-06	4.25e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.07e-06	4.21e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—INS—Parkinson's disease	7.01e-06	4.17e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—COMT—Parkinson's disease	6.92e-06	4.11e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	6.92e-06	4.11e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ADRBK1—Parkinson's disease	6.91e-06	4.11e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GSTP1—Parkinson's disease	6.89e-06	4.09e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—MAOA—Parkinson's disease	6.87e-06	4.09e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	6.86e-06	4.08e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NGF—Parkinson's disease	6.86e-06	4.08e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	6.83e-06	4.06e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CTGF—Parkinson's disease	6.79e-06	4.04e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—HMOX1—Parkinson's disease	6.79e-06	4.04e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—MAPK8—Parkinson's disease	6.76e-06	4.02e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	6.75e-06	4.01e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	6.74e-06	4.01e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—COMT—Parkinson's disease	6.69e-06	3.98e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—COMT—Parkinson's disease	6.69e-06	3.98e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—DRD2—Parkinson's disease	6.69e-06	3.98e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HTR7—Parkinson's disease	6.69e-06	3.98e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ADRBK1—Parkinson's disease	6.68e-06	3.97e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ADRBK1—Parkinson's disease	6.68e-06	3.97e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MTHFR—Parkinson's disease	6.68e-06	3.97e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GSTP1—Parkinson's disease	6.66e-06	3.96e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GSTP1—Parkinson's disease	6.66e-06	3.96e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—MAOA—Parkinson's disease	6.65e-06	3.95e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—MAOA—Parkinson's disease	6.65e-06	3.95e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	6.63e-06	3.94e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	6.63e-06	3.94e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	6.61e-06	3.93e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—HMOX1—Parkinson's disease	6.57e-06	3.91e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—HMOX1—Parkinson's disease	6.57e-06	3.91e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	6.56e-06	3.9e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—MAPK8—Parkinson's disease	6.54e-06	3.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—MAPK8—Parkinson's disease	6.54e-06	3.89e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	6.53e-06	3.88e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	6.53e-06	3.88e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ABCB1—Parkinson's disease	6.52e-06	3.88e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	6.51e-06	3.87e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	6.5e-06	3.86e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—DRD2—Parkinson's disease	6.47e-06	3.85e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—DRD2—Parkinson's disease	6.47e-06	3.85e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HTR7—Parkinson's disease	6.47e-06	3.85e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HTR7—Parkinson's disease	6.47e-06	3.85e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MTHFR—Parkinson's disease	6.46e-06	3.84e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MTHFR—Parkinson's disease	6.46e-06	3.84e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	6.45e-06	3.83e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	6.44e-06	3.83e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	6.41e-06	3.81e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	6.39e-06	3.8e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	6.33e-06	3.77e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GSTM1—Parkinson's disease	6.33e-06	3.76e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	6.33e-06	3.76e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	6.32e-06	3.75e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ABCB1—Parkinson's disease	6.31e-06	3.75e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ABCB1—Parkinson's disease	6.31e-06	3.75e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NQO1—Parkinson's disease	6.26e-06	3.72e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—APOE—Parkinson's disease	6.22e-06	3.7e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—TH—Parkinson's disease	6.17e-06	3.67e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GSTM1—Parkinson's disease	6.12e-06	3.64e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GSTM1—Parkinson's disease	6.12e-06	3.64e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	6.07e-06	3.61e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GPX1—Parkinson's disease	6.06e-06	3.6e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	6.04e-06	3.59e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NGF—Parkinson's disease	6.02e-06	3.58e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—APOE—Parkinson's disease	6.02e-06	3.58e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—APOE—Parkinson's disease	6.02e-06	3.58e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	5.93e-06	3.52e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CYCS—Parkinson's disease	5.92e-06	3.52e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NGF—Parkinson's disease	5.91e-06	3.52e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GPX1—Parkinson's disease	5.86e-06	3.49e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GPX1—Parkinson's disease	5.86e-06	3.49e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	5.82e-06	3.46e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	5.8e-06	3.45e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	5.73e-06	3.41e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	5.63e-06	3.35e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF2—Parkinson's disease	5.6e-06	3.33e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—MTHFR—Parkinson's disease	5.59e-06	3.33e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	5.54e-06	3.29e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	5.53e-06	3.28e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	5.52e-06	3.28e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CTGF—Parkinson's disease	5.42e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF2—Parkinson's disease	5.42e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF2—Parkinson's disease	5.42e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF1R—Parkinson's disease	5.42e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—MTHFR—Parkinson's disease	5.41e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—MTHFR—Parkinson's disease	5.41e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EDN1—Parkinson's disease	5.35e-06	3.18e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—APOE—Parkinson's disease	5.33e-06	3.17e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—INS—Parkinson's disease	5.31e-06	3.16e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	5.25e-06	3.12e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—COMT—Parkinson's disease	5.24e-06	3.12e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF1R—Parkinson's disease	5.24e-06	3.12e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF1R—Parkinson's disease	5.24e-06	3.12e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—APOE—Parkinson's disease	5.23e-06	3.11e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GSTP1—Parkinson's disease	5.22e-06	3.1e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CASP3—Parkinson's disease	5.22e-06	3.1e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—MAOA—Parkinson's disease	5.21e-06	3.1e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—APOE—Parkinson's disease	5.21e-06	3.1e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—INS—Parkinson's disease	5.19e-06	3.08e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—IL6—Parkinson's disease	5.18e-06	3.08e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EDN1—Parkinson's disease	5.18e-06	3.08e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EDN1—Parkinson's disease	5.18e-06	3.08e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—INS—Parkinson's disease	5.16e-06	3.07e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	5.15e-06	3.06e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—HMOX1—Parkinson's disease	5.15e-06	3.06e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—INS—Parkinson's disease	5.14e-06	3.06e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—INS—Parkinson's disease	5.14e-06	3.06e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	5.14e-06	3.05e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	5.05e-06	3e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—APOE—Parkinson's disease	5.04e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—APOE—Parkinson's disease	5.04e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NQO1—Parkinson's disease	5e-06	2.97e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—TH—Parkinson's disease	4.92e-06	2.93e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NGF—Parkinson's disease	4.92e-06	2.93e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GSTM1—Parkinson's disease	4.8e-06	2.85e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	4.8e-06	2.85e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NGF—Parkinson's disease	4.76e-06	2.83e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NGF—Parkinson's disease	4.76e-06	2.83e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CYCS—Parkinson's disease	4.73e-06	2.81e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HTR2A—Parkinson's disease	4.68e-06	2.78e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GPX1—Parkinson's disease	4.59e-06	2.73e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—INS—Parkinson's disease	4.55e-06	2.71e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HTR2A—Parkinson's disease	4.53e-06	2.69e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HTR2A—Parkinson's disease	4.53e-06	2.69e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—INS—Parkinson's disease	4.48e-06	2.66e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—INS—Parkinson's disease	4.47e-06	2.66e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—INS—Parkinson's disease	4.45e-06	2.64e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—INS—Parkinson's disease	4.4e-06	2.62e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	4.39e-06	2.61e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—APOE—Parkinson's disease	4.35e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—IL6—Parkinson's disease	4.32e-06	2.57e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—INS—Parkinson's disease	4.3e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—INS—Parkinson's disease	4.3e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL1B—Parkinson's disease	4.29e-06	2.55e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—MTHFR—Parkinson's disease	4.24e-06	2.52e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—APOE—Parkinson's disease	4.21e-06	2.5e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—APOE—Parkinson's disease	4.21e-06	2.5e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—COMT—Parkinson's disease	4.19e-06	2.49e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—IL6—Parkinson's disease	4.18e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—IL6—Parkinson's disease	4.18e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	4.17e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—MAOA—Parkinson's disease	4.16e-06	2.47e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL1B—Parkinson's disease	4.15e-06	2.47e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL1B—Parkinson's disease	4.15e-06	2.47e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	4.11e-06	2.44e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—APOE—Parkinson's disease	3.95e-06	2.35e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	3.94e-06	2.35e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—MAPK8—Parkinson's disease	3.94e-06	2.34e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	3.86e-06	2.3e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	3.84e-06	2.28e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	3.84e-06	2.28e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	3.83e-06	2.28e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	3.82e-06	2.27e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—MAPK8—Parkinson's disease	3.81e-06	2.26e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—MAPK8—Parkinson's disease	3.81e-06	2.26e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—INS—Parkinson's disease	3.72e-06	2.21e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GPX1—Parkinson's disease	3.67e-06	2.18e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—INS—Parkinson's disease	3.6e-06	2.14e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—INS—Parkinson's disease	3.6e-06	2.14e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	3.55e-06	2.11e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	3.53e-06	2.1e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	3.39e-06	2.02e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	3.38e-06	2.01e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—INS—Parkinson's disease	3.37e-06	2e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	3.37e-06	2e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	3.34e-06	1.98e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	3.33e-06	1.98e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	3.31e-06	1.97e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	3.31e-06	1.97e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	3.28e-06	1.95e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	3.27e-06	1.94e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	3.25e-06	1.93e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	3.25e-06	1.93e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOE—Parkinson's disease	3.15e-06	1.87e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	3.12e-06	1.85e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	3.07e-06	1.82e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—Parkinson's disease	3.06e-06	1.82e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	3.06e-06	1.82e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	3.01e-06	1.79e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	3e-06	1.79e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—Parkinson's disease	2.77e-06	1.65e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—Parkinson's disease	2.75e-06	1.64e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—INS—Parkinson's disease	2.69e-06	1.6e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—Parkinson's disease	2.68e-06	1.59e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—Parkinson's disease	2.68e-06	1.59e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—Parkinson's disease	2.66e-06	1.58e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—Parkinson's disease	2.66e-06	1.58e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK8—Parkinson's disease	2.55e-06	1.51e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—Parkinson's disease	2.51e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK8—Parkinson's disease	2.46e-06	1.46e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK8—Parkinson's disease	2.46e-06	1.46e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—Parkinson's disease	2.43e-06	1.45e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—Parkinson's disease	2.43e-06	1.45e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—Parkinson's disease	2.32e-06	1.38e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	2.27e-06	1.35e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.26e-06	1.34e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—Parkinson's disease	2.25e-06	1.33e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—Parkinson's disease	2.25e-06	1.33e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.99e-06	1.18e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.96e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.95e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.92e-06	1.14e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.92e-06	1.14e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—Parkinson's disease	1.63e-06	9.66e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—Parkinson's disease	1.57e-06	9.35e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—Parkinson's disease	1.57e-06	9.35e-06	CbGpPWpGaD
